| For: | Song JL, Gao W, Zhong Y, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG, Jiang L, Yang J. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. World J Gastroenterol 2016; 22(6): 2133-2141 [PMID: 26877618 DOI: 10.3748/wjg.v22.i6.2133] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i6/2133.htm |
| Number | Citing Articles |
| 1 |
Thomas Jouve, Johan Noble, Lionel Rostaing, Paolo Malvezzi. An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization. Expert Opinion on Drug Safety 2019; 18(4) doi: 10.1080/14740338.2019.1599858
|
| 2 |
Pan Kun-ming, Chen Can, Xu Qing, Wu Wei, Lv Qian-zhou, Li Xiao-yu. Calcineurin inhibitor–associated new-onset diabetes mellitus in chronic kidney disease treatment: a 4-year single-center cross-sectional study in China. European Journal of Clinical Pharmacology 2021; 77(7) doi: 10.1007/s00228-021-03095-z
|
| 3 |
Xiao-fu Xiong, Ding-ding Chen, Huai-jun Zhu, Wei-hong Ge. Prognostic Value of Endogenous and Exogenous Metabolites in Liver Transplantation. Biomarkers in Medicine 2020; 14(12) doi: 10.2217/bmm-2020-0073
|
| 4 |
Zhen Zhang, Jianyun Sun, Meng Guo, Xuemin Yuan. Progress of new-onset diabetes after liver and kidney transplantation. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1091843
|
| 5 |
Longbo Wang, Xiyang Sheng, Gengyuan Shi, Yongzhao Li, Dongdong Wang, Wei Wang, Chen Mi, Siyang Wang, Yongyue Du, Hanteng Yang. Immunometabolic remodeling: new perspectives and strategies for liver transplantation. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1776694
|
| 6 |
Tianwei Lan, Xin Zhang, Qian Yu. Anaemia associated with Tacrolimus: A case report and literature review. Journal of Clinical Pharmacy and Therapeutics 2020; 45(6) doi: 10.1111/jcpt.13238
|
| 7 |
Shingo Shimada, Katsunori Miyake, Deepak Venkat, Humberto Gonzalez, Dilip Moonka, Atsushi Yoshida, Marwan Abouljoud, Shunji Nagai. Clinical characteristics of new‐onset diabetes after liver transplantation and outcomes. Annals of Gastroenterological Surgery 2024; 8(3) doi: 10.1002/ags3.12775
|
| 8 |
Mark W. Russo, William Wheless, Dionisios Vrochides. Management of long-term complications from immunosuppression. Liver Transplantation 2024; 30(6) doi: 10.1097/LVT.0000000000000341
|
| 9 |
Shintaro Yagi, Toshimi Kaido, Taku Iida, Atsushi Yoshizawa, Hideaki Okajima, Shinji Uemoto. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function. Surgery Today 2017; 47(6) doi: 10.1007/s00595-016-1444-z
|
| 10 |
Rohit Mehtani, Jaya Agarwal, Sanjiv Saigal. Fundamentals of Transplant Hepatology. 2026; doi: 10.1007/978-981-95-2624-6_38
|
| 11 |
Johan Noble, Florian Terrec, Paolo Malvezzi, Lionel Rostaing. Adverse effects of immunosuppression after liver transplantation. Best Practice & Research Clinical Gastroenterology 2021; doi: 10.1016/j.bpg.2021.101762
|
| 12 |
Chun Xu, Hai-Ying Xiao, Bo-Yu Zhu, Fei Gao, Min Ran, Yi Wang, Hao-Yan Li. Tacrolimus induces insulin receptor substrate 1 hyperphosphorylation and inhibits mTORc1/S6K1 cascade in HL7702 cells. World Journal of Diabetes 2025; 16(2): 97910 doi: 10.4239/wjd.v16.i2.97910
|
| 13 |
Eloi Chevallier, Thomas Jouve, Lionel Rostaing, Paolo Malvezzi, Johan Noble. pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression. Expert Review of Clinical Pharmacology 2021; 14(1) doi: 10.1080/17512433.2021.1851596
|
| 14 |
Juan Manuel Rico-Juri, Anabel Vanín-Aguas, Felipe Castro-Villegas, Michael Zapata-Palomino, Ilich Andrei Zúñiga-Gaitán, Jesús David Charfuelan-Caicedo, Carolina Téllez-Fina. Eficacia y seguridad del tacrolimus en monoterapia a dosis bajas en trasplante hepático: Experiencia en un hospital nivel IV de Cali. Revista Colombiana de Cirugía 2026; doi: 10.30944/20117582.3074
|
| 15 |
Abbie D. Leino, Manjunath P. Pai. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clinical Pharmacokinetics 2020; 59(11) doi: 10.1007/s40262-020-00923-w
|
| 16 |
Chih-Yang Hsiao, Ming-Chih Ho, Cheng-Maw Ho, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu. Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation. Journal of Personalized Medicine 2021; 11(2) doi: 10.3390/jpm11020090
|
| 17 |
Mateo Chvatal‐Medina, Yakun Li, Adrian Post, Margery A. Connelly, Han Moshage, Stephan J. L. Bakker, Vincent E. de Meijer, Hans Blokzijl, Robin P. F. Dullaart. Triacylglycerol‐Based Insulin Resistance Indices and Post‐Transplantation Diabetes Mellitus After Liver Transplantation. Lipids 2026; doi: 10.1002/lipd.70048
|
| 18 |
Nikola Bakovic, Ivana Pantic, Ivana Vasiljevic, Marko Vojnovic, Dusan Micic, Tamara Milovanovic. Tacrolimus-Associated Adverse Effects After Liver Transplantation: A Narrative Review. Journal of Clinical Medicine 2026; 15(11) doi: 10.3390/jcm15114176
|
| 19 |
Robert E Dupuis, Alfred Sidney Barritt, Chirag S Desai, Ruth-Ann Lee, Sarah R Lieber, Prani Paka. Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review. World Journal of Transplantation 2018; 8(3): 75-83 doi: 10.5500/wjt.v8.i3.75
|
| 20 |
Antônio Ricardo Cardia Ferraz de Andrade, Helma P. Cotrim, Paulo L. Bittencourt, Carolina G. Almeida, Ney Christian Amaral Boa Sorte. Nonalcoholic steatohepatitis in posttransplantation liver: Review article. Revista da Associação Médica Brasileira 2018; 64(2) doi: 10.1590/1806-9282.64.02.187
|
| 21 |
Aloysious D. Aravinthan, Waleed Fateen, Adam C. Doyle, Suresh V. Venkatachalapathy, Assaf Issachar, Zita Galvin, Gonzalo Sapisochin, Mark S. Cattral, Anand Ghanekar, Ian D. McGilvray, Markus Selzner, David R. Grant, Nazia Selzner, Leslie B. Lilly, Eberhard L. Renner, Mamatha Bhat. The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation. Transplantation 2019; 103(12) doi: 10.1097/TP.0000000000002757
|
| 22 |
Sonja Beckmann, Gerda Drent, Todd Ruppar, Nataša Nikolić, Sabina De Geest. Body Weight Parameters are Related to Morbidity and Mortality After Liver Transplantation: A Systematic Review and Meta-analysis. Transplantation 2019; 103(11) doi: 10.1097/TP.0000000000002811
|
| 23 |
Jongman Kim, Jae-Won Joh, Kwang-Woong Lee, Dong Lak Choi, Hee-Jung Wang. Safety and efficacy of early corticosteroid withdrawal in liver transplant recipients: A randomized controlled trial. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2) doi: 10.14701/ahbps.23-129
|
| 24 |
Mariana Baldini Campos, Cínthia Minatel Riguetto, Ilka de Fátima Santana Ferreira Boin, Arnaldo Moura. Risk factors associated with diabetes after liver transplant. Archives of Endocrinology and Metabolism 2022; doi: 10.20945/2359-3997000000447
|
| 25 |
Rohit Mehtani, Sanjiv Saigal. Long Term Complications of Immunosuppression Post Liver Transplant. Journal of Clinical and Experimental Hepatology 2023; 13(6) doi: 10.1016/j.jceh.2023.06.007
|
| 26 |
Tommaso Maria Manzia, Roberta Angelico, Luca Toti, Cristina Angelico, Claudia Quaranta, Alessandro Parente, Francesca Blasi, Samuele Iesari, Daniele Sforza, Leonardo Baiocchi, Jan Lerut, Giuseppe Tisone. Longterm Survival and Cost‐Effectiveness of Immunosuppression Withdrawal After Liver Transplantation. Liver Transplantation 2018; 24(9) doi: 10.1002/lt.25293
|
| 27 |
Chengbo Ai, Jiulin Song, Chi Yuan, Gang Xu, Jian Yang, Tao Lv, Shuguang Jin, Hong Wu, Bo Xiang, Jiayin Yang. Prediction model of the T cell-mediated rejection after liver transplantation in children and adults: A case-controlled study. International Journal of Surgery 2025; 111(4) doi: 10.1097/JS9.0000000000002279
|
| 28 |
Poh Seng Tan, Mark D. Muthiah, Tsingyi Koh, Yee Leong Teoh, Albert Chan, Alfred Kow, Qishi Zheng, Choon Hyuck David Kwon, Guan Huei Lee, Cosmas Rinaldi A. Lesmana, Vanessa de Villa, James Fung, Kieron Lim. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation. Transplantation 2019; 103(3) doi: 10.1097/TP.0000000000002532
|
| 29 |
Ruiping Bai, Rui An, Siyu Chen, Wenkang Ding, Mengwen Xue, Ge Zhao, Qingyong Ma, Xin Shen. Risk factors and prediction score for new‐onset diabetes mellitus after liver transplantation. Journal of Diabetes Investigation 2024; 15(8) doi: 10.1111/jdi.14204
|
| 30 |
Ali R Chaitou, Surbhi Valmiki, Mrinaal Valmiki, Maria Zahid, Mohamed A Aid, Peter Fawzy, Safeera Khan. New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy. Cureus 2022; doi: 10.7759/cureus.23635
|
| 31 |
Venkat Bhat, Mahmood Tazari, Kymberly D. Watt, Mamatha Bhat. New-Onset Diabetes and Preexisting Diabetes Are Associated With Comparable Reduction in Long-Term Survival After Liver Transplant: A Machine Learning Approach. Mayo Clinic Proceedings 2018; 93(12) doi: 10.1016/j.mayocp.2018.06.020
|
| 32 |
Chang Seong Kim, Ansuja Pulickal Mathew, Arathy Vasukutty, Saji Uthaman, Soo Yeon Joo, Eun Hui Bae, Seong Kwon Ma, In-Kyu Park, Soo Wan Kim. Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-00857-w
|
| 33 |
Yip Han Chin, Hon Qin Marcus Tan, Cheng Han Ng, Darren Jun Hao Tan, Snow Yunni Lin, Daniel Q. Huang, Chin Meng Khoo, Mark Dhinesh Muthiah. A Time-Based Meta-Analysis on the Incidence of New Onset Diabetes after Liver Transplantation. Journal of Clinical Medicine 2021; 10(5) doi: 10.3390/jcm10051045
|